A Study of Therapeutic Amplitude-modulated Electromagnetic Fields in Advanced Tumors (THBC001)

This study has been completed.
Sponsor:
Collaborator:
Barbault, Alexandre, M.S.
Information provided by:
Pasche, Boris, M.D.
ClinicalTrials.gov Identifier:
NCT00440570
First received: February 24, 2007
Last updated: June 28, 2011
Last verified: June 2011
  Purpose

In vitro studies suggest that low levels of amplitude-modulated electromagnetic fields may modify cell growth. We have identified specific frequencies that may block cancer cell growth. We have developed a device delivering low levels of amplitude-modulated electromagnetic fields. The device is connected to a spoon-like coupler, which is placed in the patient's mouth during treatment. We will conduct a feasibility study consisting of three daily ambulatory treatments until disease progression.


Condition Intervention Phase
Cancer
Brain Tumor
Device: Low levels of amplitude-modulated electromagnetic fields
Device: Emitter of low levels of amplitude-modulated electromagnetic fields
Phase 0

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Official Title: Treatment of Advanced Cancer With Amplitude-modulated Electromagnetic Fields of Low Intensity by Means of an Intrabuccal Probe

Resource links provided by NLM:


Further study details as provided by Pasche, Boris, M.D.:

Primary Outcome Measures:
  • Safety of daily administration of amplitude-modulated electromagnetic fields in patients with advanced cancer

Secondary Outcome Measures:
  • Complete blood count, comprehensive chemistry profile, tumor markers
  • Tumor assessment as per RECIST criteria

Estimated Enrollment: 2
Study Start Date: October 2004
Study Completion Date: December 2007
Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)
Detailed Description:

Background: In vitro studies suggest that low levels of amplitude-modulated electromagnetic fields may modify cell growth. We have identified specific frequencies that may block cancer cell growth. We have developed a portable and programmable device delivering low levels of amplitude-modulated electromagnetic fields. The device is connected to a spoon-like coupler, which is placed in the patient's mouth during treatment.

Methods: We will conducted a feasibility study consisting of three daily treatments. All patients with advanced solid tumors and measurable disease will be eligible, irrespective of prior treatments. Patients will be assessed with laboratory exams (complete blood count, comprehensive profile, tumor markers), imaging studies every other month for the first six months, every third month thereafter.

  Eligibility

Ages Eligible for Study:   18 Years to 95 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Advanced tumor that is either metastatic or inoperable

Exclusion Criteria:

  • Pregnancy,
  • Other simultaneous anticancer therapies,
  • ECOG performance status less than 3
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00440570

Locations
Switzerland
Cabinet Médical Avenue de la gare 6
Lausanne, Vaud, Switzerland, 1012
Sponsors and Collaborators
Pasche, Boris, M.D.
Barbault, Alexandre, M.S.
Investigators
Principal Investigator: Boris C Pasche, MD, PhD Cabinet Médical Avenue de la gare 6
  More Information

Publications:
Responsible Party: Boris Pasche
ClinicalTrials.gov Identifier: NCT00440570     History of Changes
Other Study ID Numbers: 001
Study First Received: February 24, 2007
Last Updated: June 28, 2011
Health Authority: Switzerland: Laws and standards

Keywords provided by Pasche, Boris, M.D.:
cancer
electromagnetic fields
treatment

Additional relevant MeSH terms:
Brain Neoplasms
Central Nervous System Neoplasms
Nervous System Neoplasms
Neoplasms by Site
Neoplasms
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on April 17, 2014